marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2022-Q3
added 11-08-2022
Albireo Pharma Financial Ratios 2011-2024 | ALBO
Annual Financial Ratios Albireo Pharma
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-15.8 | -6.5 | -4.3 | -6.2 | -11.4 | -2.9 | -0.8 | -2.3 | -2.0 | -1.5 | -2.4 |
P/S |
13.3 | 84.2 | 28.2 | 22.3 | 277507.0 | - | - | - | - | - | - |
EPS |
-1.8 | -6.7 | -5.0 | -3.9 | -3.1 | -13.2 | -25.5 | -0.7 | -1.2 | -1.9 | -0.3 |
EV (Enterprise Value) |
417 M | 553 M | 211 M | 183 M | 232 M | 12.2 M | 11.9 M | 10.8 M | 8.4 M | 1.76 M | -8.73 M |
EBITDA per Share |
-6.41 | -5.03 | -4.9 | -3.23 | -3.14 | -6.51 | -14.3 | -26.2 | -38.2 | -51.2 | -85.8 |
EV/EBITDA |
-3.4 | -4.8 | -2.3 | -3.2 | -9.1 | -0.8 | 1.3 | -0.4 | 0.0 | 0.5 | 0.6 |
PEG |
-2.41 | 0.19 | 0.15 | 0.25 | -0.15 | -0.05 | -0.03 | -0.05 | -0.06 | 0.04 | -0.03 |
P/B |
3.1 | 3.9 | 2.9 | 2.3 | 4.3 | 1.5 | 0.4 | 1.4 | 1.2 | 1.0 | 0.7 |
P/CF |
-5.0 | -6.9 | -5.1 | -10.6 | -10.0 | -3.2 | -0.8 | -1.7 | -2.1 | -1.8 | -1.4 |
ROE % |
-19.38 | -59.39 | -67.32 | -37.60 | -37.41 | -52.03 | -47.37 | -61.99 | -59.38 | -66.89 | -28.57 |
ROA % |
-11.27 | -37.69 | -37.99 | -24.86 | -33.34 | -47.65 | -45.23 | -55.58 | -46.99 | -50.44 | -25.52 |
ROCE % |
-70.32 | -36.98 | -41.82 | -21.95 | -37.64 | -52.13 | -49.90 | -80.90 | -53.20 | -50.32 | -60.77 |
Current Ratio |
2.4 | 10.4 | 7.5 | 13.1 | 6.9 | 13.9 | 22.7 | 15.4 | 16.4 | 14.2 | 11.9 |
DSO |
14.7 | - | - | 83.5 | 264990.0 | - | - | - | - | - | - |
DIO |
26.1 | - | - | - | - | - | - | - | - | - | - |
DPO |
1588.0 | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
40.8 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
-1547.2 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Albireo Pharma
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | -1.92 | -2.04 | -2.19 | - | 2.96 | -1.9 | -2.29 | - | -1.96 | -1.38 | -2.23 | - | -1.73 | -1.35 | -1.39 | - | -1.17 | -1.22 | -0.15 | - | -0.73 | -0.86 | -1.06 | - | -13.32 | 7.42 | -12.2 | -0.05 | -0.46 | -0.12 | -0.18 | -0.2 | -0.56 | -0.15 | -0.2 | -0.12 | -0.04 | -0.66 | -0.12 | -0.26 | -0.42 | -0.6 | -0.26 | -0.47 | 0.43 | -0.48 | -0.82 |
EBITDA per Share |
- | -1.75 | -1.89 | -2.04 | - | -2.03 | -1.72 | -2.08 | - | -1.72 | -1.21 | -2.09 | - | -1.62 | -1.23 | -1.28 | - | -1.06 | -0.87 | -0.05 | - | -0.73 | -0.92 | -0.97 | - | -11.3 | 6.76 | -9.87 | - | 0.01 | - | - | - | 0.02 | 0.01 | - | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.04 | 0.04 | 0.01 | 0.02 | 0.08 | 0.06 | 0.03 |
ROE % |
-101.55 | -70.14 | -0.95 | 2.11 | -30.24 | -47.20 | -95.58 | -74.86 | -45.71 | -69.22 | -75.78 | -82.26 | -59.25 | -70.68 | -58.60 | -52.66 | -24.67 | -34.64 | -33.19 | -30.74 | -29.67 | -40.57 | -41.50 | -26.25 | -13.88 | 22.90 | -5.39 | -27.52 | -30.70 | 134.02 | 121.26 | 123.54 | 110.66 | -98.87 | -49.41 | -94.73 | -77.41 | -81.21 | -97.66 | -105.18 | -110.83 | -112.46 | -82.36 | -486.87 | -487.18 | 11.15 | -471.40 | -13.46 |
ROA % |
-45.45 | -26.20 | 4.83 | 5.68 | -14.84 | -25.61 | -55.63 | -46.25 | -29.00 | -42.28 | -44.79 | -47.64 | -33.44 | -41.00 | -35.29 | -33.09 | -16.31 | -25.20 | -26.53 | -27.09 | -26.44 | -34.55 | -33.78 | -21.03 | -10.33 | -56.43 | -85.74 | -105.65 | -110.62 | -86.80 | -95.95 | -92.96 | -99.90 | -84.23 | -39.62 | -74.00 | -61.51 | -64.74 | -77.05 | -80.51 | -83.49 | -85.47 | -61.22 | -431.90 | -433.83 | 9.96 | -421.12 | -10.84 |
ROCE % |
-94.05 | -115.62 | -102.55 | -98.92 | -77.56 | -92.51 | -85.90 | -66.85 | -41.31 | -63.46 | -70.66 | -77.01 | -55.02 | -65.35 | -53.53 | -45.61 | -19.29 | -29.30 | -28.99 | -30.63 | -29.49 | -38.79 | -38.08 | -22.70 | -11.15 | -11.15 | -1.85 | -7.10 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | 1.4 | 2.0 | 2.3 | 2.4 | 2.6 | 2.1 | 2.5 | 2.7 | 2.7 | 2.7 | 2.7 | 2.3 | 2.3 | 2.3 | 2.3 | 3.0 | 3.0 | 3.0 | 3.0 | 9.2 | 9.2 | 9.2 | 9.2 | 3.9 | 3.9 | 3.9 | 3.9 | 0.5 | 22.2 | 22.2 | 25.9 | 9.8 | 9.7 | 9.7 | 9.7 | 5.6 | 4.8 | 4.8 | 4.8 | 4.0 | 4.1 | 4.1 | 4.1 | 8.2 | 9.4 | 9.4 | 9.4 |
DSO |
- | 18.0 | 17.4 | 30.4 | - | 16.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 250.9 | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | 391.0 | 230.3 | 392.9 | - | 20.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | 920.2 | 691.6 | 2512.3 | - | 1368.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | 409.0 | 247.7 | 423.2 | - | 37.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 250.9 | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | -511.2 | -443.9 | -2089.1 | - | -1331.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 250.9 | 45.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency